Contact

Publications

Publications

See our most recent publications in the section below.

  • Overbeek JA, Swart KMA, van der Pal EYM, et al. The DIAbetes MANagement and Treatment (DIAMANT) Cohort. Clin Epidemiol 2022; 14: 1453-62.
  • Dal Canto E, Remmelzwaal S, van Ballegooijen AJ, Handoko ML, Heymans S, van Empel V, Paulus WJ, Nijpels G, Elders P, Beulens JW. Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction. Heart Fail Rev. 2022; 27(1):207-218.
  • Van Dongen LH, Harms PP, Hoogendoorn M, Zimmerman DS, Lodder EM, 't Hart LM, Herings R, van Weert HCPM, Nijpels G, Swart KMA, van der Heijden AA, Blom MT, Elders PJ, Tan HL. Discovery of predictors of sudden cardiac arrest in diabetes: rationale and outline of the RESCUED (REcognition of Sudden Cardiac arrest vUlnErability in Diabetes) project. Open Heart. 2021;8(1):e001554.
  • Harms PP, van der Heijden AA, Rutters F, Tan HL, Beulens JWJ, Nijpels G, Elders P; ESCAPE-NET. Prevalence of ECG abnormalities in people with type 2 diabetes: The Hoorn Diabetes Care System cohort. J Diabetes Complications. 2021;35(2):107810
  • Schreur V, Ng H, Nijpels G, Stefánsson E, Tack CJ, Klevering BJ, de Jong EK, Hoyng CB, Keunen JEE, van der Heijden AA. Validation of a model for the prediction of retinopathy in persons with type 1 diabetes. Br J Ophthalmol. 2021;105(9):1286-1288.
  • Nijpels G, van der Heijden AAWA, Elders P, Beulens JWJ, de Vet HCW. The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes. PLoS One. 2021 12;16(8):e0255466.
  • Beulens JWJ, Yauw JS, Elders PJM, Feenstra T, Herings R, Slieker RC, Moons KGM, Nijpels G, van der Heijden AA. Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes: a systematic review and external validation study. Diabetologia. 2021;64(7):1550-1562.
  • Nijpels G, Beulens JW, van der Heijden AA, Elders PJ. Innovations in personalised diabetes care and risk management. Eur J Prev Cardiol. 2019 Dec;26(2_suppl):125-132.
  • Overbeek JA, Kuiper JG, van der Heijden AAWA, Labots M, Haug U, Herings RMC, Nijpels G. Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes. Int J Colorectal Dis 2019; 34(2): 269-276.
  • Overbeek JA, van Herk-Sukel MPP, Vissers PAJ, van der Heijden AAWA, Bronsveld HK, Herings RMC, Schmidt MK, Nijpels G. Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries. Diabetes Care 2019; 42(3): 434-442.
  • Overbeek JA, Heintjes EM, Huisman EL, Tikkanen CK, van Diermen AW, Penning-van Beest FJA, Herings RMC. Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes. Diabetes Obes Metab 2018; 20(9): 2093-2102.
  • Rutters F, Nijpels G, Elders P, Stehouwer CDA, van der Heijden AA, Groeneveld L, 't Hart LM, Dekker JM, Beulens JWJ. Cohort Profile: The Hoorn Studies. Int J Epidemiol. 2018 Apr 1;47(2):396-396j.
  • Heintjes EM, Overbeek JA, Hall GC, Prieto-Alhambra D, Lapi F, Hammar N, Bezemer ID. Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries. Clin Ther 2017; 39(11): 2296-2310 e14.
  • Van Wijngaarden RPT, Overbeek JA, Heintjes EM, Schubert A, Diels J, Straatman H, Steyerberg EW, Herings RMC. Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study. Diabetes Ther 2017; 8(5): 1097-1109.
  • Overbeek JA, Heintjes EM, Prieto-Alhambra D, Blin P, Lassalle R, Hall GC, Lapi F, Bianchini E, Hammar N, Bezemer ID, Herings RMC. Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study. Clin Ther 2017; 39(4): 759-770.
  • Overbeek JA, van der Heijden AW, Herings RM, Nijpels G. [Prevalence of diabetes mellitus in the Netherlands more than doubled in the period 1999-2014]. Ned Tijdschr Geneeskd 2017; 160: D673.
  • Van der Heijden AA, Rauh SP, Dekker JM, Beulens JW, Elders P, 't Hart LM, Rutters F, van Leeuwen N, Nijpels G. The Hoorn Diabetes Care System (DCS) cohort. A prospective cohort of persons with type 2 diabetes treated in primary care in the Netherlands. BMJ Open. 2017 Jun 6;7(5):e015599.

More info?

Interested to learn more about the DIAbetes MANagement and Treatment (Diamant), the DIAMANT Cohort and the national infrastructure of STIZON? Do not hesitate to contact us. 

Contact us